Endogenous cholecystokinin’s satiating action increases during estrus in female rats

L. Eckel,N. Geary

DOI: https://doi.org/10.1016/S0196-9781(99)00025-X

IF: 3.867

1999-05-01

Peptides

Abstract:

What problem does this paper attempt to address?

Intramyocardial Injection of a Fully Synthetic Hydrogel Attenuates Left Ventricular Remodeling Post Myocardial Infarction.

Yasumoto Matsumura,Yang Zhu,Hongbin Jiang,Antonio D'Amore,Samuel K. Luketich,Verena Charwat,Tomo Yoshizumi,Hideyoshi Sato,Brenda Yang,Takafumi Uchibori,Kevin E. Healy,William R. Wagner

DOI: https://doi.org/10.1016/j.biomaterials.2019.119289

IF: 14

2019-01-01

Biomaterials

Abstract:Intramyocardial hydrogel injection is an innovative and promising treatment for myocardial infarction (MI) and has recently entered clinical trials. By providing mechanical support to the ventricular wall, hydrogel injectate may act to preserve cardiac function and slow the remodeling process that leads to heart failure. However, improved outcomes will likely depend on the use of hydrogels specifically designed for this unique application, and better understanding of the mechanisms affected by the intervention. In this work, we present the first large animal study achieving functional and geometrical improvements in treating MI using a relatively stiff, fully synthetic hydrogel designed for intramyocardial injection. In addition, the renin-angiotensin system coincided with the mechanical effects of hydrogel injection and attenuated left ventricular remodeling, even after significant hydrogel degradation had occurred in vivo. These results may inspire further optimization of hydrogel materials used in intramyocardial hydrogel injection therapy and a better description of physiologic pathways affected by its implementation to facilitate successful clinical translation.
Timing Effect of Intramyocardial Hydrogel Injection for Positively Impacting Left Ventricular Remodeling after Myocardial Infarction.

Tomo Yoshizumi,Yang Zhu,Hongbin Jiang,Antonio D'Amore,Hirokazu Sakaguchi,Jason Tchao,Kimimasa Tobita,William R Wagner

DOI: https://doi.org/10.1016/j.biomaterials.2015.12.002

IF: 14

2015-01-01

Biomaterials

Abstract:Intramyocardial injection of various injectable hydrogel materials has shown benefit in positively impacting the course of left ventricular (LV) remodeling after myocardial infarction (MI). However, since LV remodeling is a complex, time dependent process, the most efficacious time of hydrogel injection is not clear. In this study, we injected a relatively stiff, thermoresponsive and bioabsorbable hydrogel in rat hearts at 3 different time points - immediately after MI (IM), 3 d post-MI (3D), and 2 w post-MI (2W), corresponding to the beginnings of the necrotic, fibrotic and chronic remodeling phases. The employed left anterior descending coronary artery ligation model showed expected infarction responses including functional loss, inflammation and fibrosis with distinct time dependent patterns. Changes in LV geometry and contractile function were followed by longitudinal echocardiography for 10 w post-MI. While all injection times positively affected LV function and wall thickness, the 3D group gave better functional outcomes than the other injection times and also exhibited more local vascularization and less inflammatory markers than the earlier injection time. The results indicate an important role for injection timing in the increasingly explored concept of post-MI biomaterial injection therapy and suggest that for hydrogels with mechanical support as primary function, injection at the beginning of the fibrotic phase may provide improved outcomes.
Abstract 16617: Multimodality Imaging Approach in Delivery and Tracking of a Novel Imageable Hydrogel in a Chronic Porcine Infarct Model

Inga H Melvinsdottir,Shin-rong Lee,Ricardo Avendano,Dan Midgett,Yi-Hwa Liu,Stephanie Thorn,christi hawley,Marina Mamarian,Selen Uman,Jay D Humphrey,James Duncan,Jason A Burdick,Albert J Sinusas

DOI: https://doi.org/10.1161/circ.142.suppl_3.16617

IF: 37.8

2020-11-17

Circulation

Abstract:Introduction: Left ventricular (LV) remodeling is a known complication from myocardial infarction (MI). Intramyocardial hydrogel (HG) delivery can potentially prevent LV remodeling post MI. We evaluated the feasibility of using multimodality imaging approach to assess the delivery and response to an imageable HG in a chronic porcine MI model. Methods: Nine Yorkshire pigs subjected to 90 min balloon occlusion and reperfusion were randomized 5 days post MI to delivery of HG (n=5) or controls (n=4). 99m Tc-Tetrofosmin was injected during the occlusion to assess risk area (RA). The imageable HG (Hyaluronic Acid/Gelatin modified with Aldehydes and Hydrazides, with 100 mg/mL iohexol) was delivered intramyocardially in a 3x3 grid 5 days post-MI after assessing MI region with Hybrid 201 Tl SPECT/CT. Contrast cineCT angiography was performed at baseline, 5 days post MI and 1 hour and 1 week post thoracotomy to assess LV geometry, HG location and CT intensity expressed as Hounsfield units (HU). Results: The average RA was 16.7% LV with no difference between the groups (p=0.44). The HG was delivered to the MI region with guidance of SPECT/CT. The HG was visible with cineCT post-delivery within perfusion defect (MI: 154 ± 26 HU; remote 82 ± 20 HU, p<0.0001), but it was not visible 1 week post-delivery (MI: 79 ± 12 HU; remote 80 ± 14 HU, p=0.94). The wall thickening of the MI region dropped by 33% in both groups (p=0.99) at 5 days post MI. After HG delivery wall thickening increased by 33% in the HG group but decreased by 31% in the control group (HG: 2.42 ± 0.33 mm; Control: 1.25 ± 0.31 mm, p=0.041). After similar increase in end diastolic volume (EDV) 5 days post MI (p=0.43), the EVD was significantly reduced post HG delivery in the HG group (6.0 ± 2.0 ml reduction) compared to the control group (6.3 ± 4.4 ml increase, p=0.042). Conclusions: Multimodality imaging is a feasible method to guide and track the delivery of a novel imageable HG. Intramyocardial HG delivery was associated with decreased LV remodeling.

cardiac & cardiovascular systems,peripheral vascular disease
BIODEGRADABLE, THERMALLY RESPONSIVE HYDROGELS FOR MYOCARDIAL INFARCTION TREATMENT

Yang Zhu

2017-01-01

Abstract:Myocardial infarction (MI) is one of the leading causes of human mortality and morbidity. Aimed at preventing post-MI pathological left ventricular remodeling, which leads to end-stage heart failure, intramyocardial biomaterial injection was developed and has been rapidly advancing as a strategy to provide mechanical support to the ventricular wall. Various material candidates have been evaluated in clinical and preclinical trials and have presented promising therapeutic outcomes. This growing body of research has stimulated efforts to optimize material properties, identify key mechanistic factors, and implement safer, more adaptable delivery methods. We previously invented a series of poly(N-isopropylacrylamide) (polyNIPAAm) based thermally responsive injectable hydrogels which could become hydrophilic and be absorbed in vivo as labile hydrophobic polyester side chains are removed. With advantageous mechanical properties, these hydrogels has shown beneficial effects in small and large animal models of MI. At the same time, there is considerable room for improvement in material design. Hydrogel degradation rates could not be precisely manipulated across a wide range. High viscosity and sol-gel transition of hydrogel solutions below body temperature prohibited catheter based delivery. The bioactivity of the synthetic hydrogels was low, not specifically incorporating activity designed to mitigate adverse responses of MI and the injected hydrogel itself. Modifications were made on the previous hydrogel platform. We employed the concept of “acid-catalyzed degradation” documented in polyester based scaffold materials and developed an innovative strategy of tailoring the degradation rate of the hydrogel. This allowed tuning hydrogel degradation time from days to months. By copolymerization with more hydrophilic monomers, injectability of the hydrogels through catheters was substantially increased. Patterned subxiphoid transepicardial injections on a beating porcine heart were achieved facilitated by a miniature robotic delivery device. Scavengers for reactive oxygen species were incorporated into the platform design, producing an antioxidant hydrogel which significantly mitigated infarction/reperfusion injury in rat hearts and reduced ventricular cell apoptosis. In a parallel study a connective porous structure was generated in the injected hydrogel and decellularized porcine urinary bladder components were added. Cell infiltration into these hydrogels was greatly increased, and macrophages were polarized towarding a more constructive phenotype.
Myocardial Injection of a Thermoresponsive Hydrogel with Reactive Oxygen Species Scavenger Properties Improves Border Zone Contractility

Kimberly A. Spaulding,Yang Zhu,Kiyoaki Takaba,Anusuya Ramasubramanian,Anusha Badathala,Henrik Haraldsson,Alexander Collins,Esteban Aguayo,Curran Shah,Arthur W. Wallace,Nicholas P. Ziats,David H. Lovett,Anthony J. Baker,Kevin E. Healy,Mark B. Ratcliffe

DOI: https://doi.org/10.1002/jbm.a.36941

2020-01-01

Journal of Biomedical Materials Research Part A

Abstract:The decrease in contractility in myocardium adjacent (border zone; BZ) to a myocardial infarction (MI) is correlated with an increase in reactive oxygen species (ROS). We hypothesized that injection of a thermoresponsive hydrogel, with ROS scavenging properties, into the MI would decrease ROS and improve BZ function. Fourteen sheep underwent antero-apical MI. Seven sheep had a comb-like copolymer synthesized from N-isopropyl acrylamide (NIPAAm) and 1500 MW methoxy poly(ethylene glycol) methacrylate, (NIPAAm-PEG1500), injected (20 x 0.5 mL) into the MI zone 40 min after MI (MI + NIPAAm-PEG1500) and seven sheep were MI controls. Cardiac MRI was performed 2 weeks before and 6 weeks after MI + NIPAAm-PEG1500. BZ wall thickness at end systole was significantly higher for MI + NIPAAm-PEG1500 (12.32 +/- 0.51 mm/m(2) MI + NIPAAm-PEG1500 vs. 9.88 +/- 0.30 MI; p = .023). Demembranated muscle force development for BZ myocardium 6 weeks after MI was significantly higher for MI + NIPAAm-PEG1500 (67.67 +/- 2.61 mN/m(2) MI + NIPAAm-PEG1500 vs. 40.53 +/- 1.04 MI; p < .0001) but not significantly different from remote myocardium or BZ or non-operated controls. Levels of ROS in BZ tissue were significantly lower in the MI + NIPAAm-PEG1500 treatment group (hydroxyl p = .0031; superoxide p = .0182). We conclude that infarct injection of the NIPAAm-PEG1500 hydrogel with ROS scavenging properties decreased ROS and improved contractile protein function in the border zone 6 weeks after MI.
Matrix Metalloproteinase-Targeted SPECT/CT Imaging for Evaluation of Therapeutic Hydrogels for the Early Modulation of Post-Infarct Myocardial Remodeling

Stephanie L. Thorn,James A. Shuman,Mitchel R. Stacy,Brendan P. Purcell,Heather Doviak,Jason A. Burdick,Francis G. Spinale,Albert J. Sinusas

DOI: https://doi.org/10.1007/s12265-022-10280-7

2022-06-14

Journal of Cardiovascular Translational Research

Abstract:Following myocardial infarction (MI), maladaptive upregulation of matrix metalloproteinase (MMP) alters extracellular matrix leading to cardiac remodeling. Intramyocardial hydrogel delivery provides a vehicle for local delivery of MMP tissue inhibitors (rTIMP-3) for MMP activity modulation. We evaluated swine 10–14 days following MI randomized to intramyocardial delivery of saline, degradable hyaluronic acid (HA) hydrogel, or rTIMP-3 releasing hydrogel with an MMP-targeted radiotracer ( 99m Tc-RP805), 201 Tl, and CT. Significant left ventricle (LV) wall thinning, increased wall stress, reduced circumferential wall strain occurred in the MI region of MI-Saline group along with left atrial (LA) dilation, while these changes were modulated in both hydrogel groups. 99m Tc-RP805 activity increased twofold in MI-Saline group and attenuated in hydrogel animals. Infarct size significantly reduced only in rTIMP-3 hydrogel group. Hybrid SPECT/CT imaging demonstrated a therapeutic benefit of intramyocardial delivery of hydrogels post-MI and reduced remodeling of LA and LV in association with a reduction in MMP activation.

cardiac & cardiovascular systems,medicine, research & experimental
Design of a Coupled Thermoresponsive Hydrogel and Robotic System for Postinfarct Biomaterial Injection Therapy.

Yang Zhu,Nathan A Wood,Kevin Fok,Tomo Yoshizumi,Dae Woo Park,Hongbin Jiang,David S Schwartzman,Marco A Zenati,Takafumi Uchibori,William R Wagner,Cameron N Riviere

DOI: https://doi.org/10.1016/j.athoracsur.2016.02.082

IF: 5.113

2016-01-01

The Annals of Thoracic Surgery

Abstract:BACKGROUND:In preclinical testing, ventricular wall injection of hydrogels has been shown to be effective in modulating ventricular remodeling and preserving cardiac function. For some approaches, early-stage clinical trials are under way. The hydrogel delivery method varies, with minimally invasive approaches being preferred. Endocardial injections carry a risk of hydrogel regurgitation into the circulation, and precise injection patterning is a challenge. An epicardial approach with a thermally gelling hydrogel through the subxiphoid pathway overcomes these disadvantages.METHODS:A relatively stiff, thermally responsive, injectable hydrogel based on N-isopropylacrylamide and N-vinylpyrrolidone (VP gel) was synthesized and characterized. VP gel thermal behavior was tuned to couple with a transepicardial injection robot, incorporating a cooling feature to achieve injectability. Ventricular wall injections of the optimized VP gel have been performed ex vivo and on beating porcine hearts.RESULTS:Thermal transition temperature, viscosity, and gelling time for the VP gel were manipulated by altering N-vinylpyrrolidone content. The target parameters for cooling in the robotic system were chosen by thermal modeling to support smooth, repeated injections on an ex vivo heart. Injections at predefined locations and depth were confirmed in an infarcted porcine model.CONCLUSIONS:A coupled thermoresponsive hydrogel and robotic injection system incorporating a temperature-controlled injectate line was capable of targeted injections and amenable to use with a subxiphoid transepicardial approach for hydrogel injection after myocardial infarction. The confirmation of precise location and depth injections would facilitate a patient-specific planning strategy to optimize injection patterning to maximize the mechanical benefits of hydrogel placement.
Intervening to preserve function in ischemic cardiomyopathy with a porous hydrogel and extracellular matrix composite in a rat myocardial infarction model

Yasunari Hayashi,Taro Fujii,Seungil Kim,Stephen F Badylak,Antonio D'Amore,William R Wagner

DOI: https://doi.org/10.1101/2024.07.02.601690

2024-07-04

Abstract:A variety of hydrogels have been developed for intramyocardial injection therapy after myocardial infarction. Some of these biomaterials have incorporated bioactive substances that promote local tissue regeneration and integration, while others have emphasized the mechanical role of the injectate in providing functional benefit. In this study, we incorporated two bioactive features, porosity, and extracellular matrix derived hydrogel (ECM), into a mechanically optimized, thermoresponsive, degradable hydrogel (poly(N-isopropylacrylamide-co-N-vinylpyrrolidone-co-MAPLA) copolymer) and evaluated whether injection of this biomaterial could abrogate the remodeling process in a rat ischemic cardiomyopathy model. After myocardial infarction by coronary artery ligation, rats were randomly divided into four groups: group NP (non-porous hydrogel) without either ECM or porosity, group PM (porous hydrogel) from the same synthetic copolymer with mannitol beads as porogens, and group PME with porosity and ECM digest added to the synthetic copolymer. A group with PBS injection alone served as a control. Intramyocardial injections were made 3 days after myocardial infarction. Serial echocardiography was assessed over time, and histological assessments were performed eight weeks after infarction. Results demonstrated improved echocardiographic function and neovascularization in the PME group compared to the other hydrogels and PBS injection. The PME group also demonstrated significant improvement in LV geometry and macrophage polarization (towards M2) compared to the PBS group, whereas these differences were not observed in the NP or PM groups versus the control. These results demonstrate that further functional improvement may be achieved in hydrogel injection therapy for ischemic cardiomyopathy by incorporating porosity and ECM digest, representing a combination of mechanical and biological effects.

Bioengineering
Tuning Biphenyl Dioxygenase for Extended Substrate Specificity and Enhanced Activity

Wilfred Chen

DOI: https://doi.org/10.21236/ada335315

1997-09-30

Abstract:Abstract : At the time when public concern about PCBs contamination in the environment is increasing, there is also an increasing interest in the development of novel biodegradation processes that can rapidly and effectively remove PCB's. However, some of the PCB congeners are known to be very resistant to aerobic biodegradation, particularly in the initial attack by the biphenyl dioxygenases. We seek to broaden the substrate specificity of biphenyl dioxygenase from Pseudomonas sp.
Imaging of Injectable Hydrogels Delivered into Myocardium with SPECT/CT

Selen Uman,Leo L. Wang,Stephanie L. Thorn,Zhao Liu,James S Duncan,Albert J. Sinusas,Jason A. Burdick

DOI: https://doi.org/10.1002/adhm.202000294

IF: 10

2020-06-15

Advanced Healthcare Materials

Abstract:Injectable hydrogels are being widely explored for treatment after myocardial infarction (MI) through mechanical bulking or the delivery of therapeutics. Despite this interest, there have been few approaches to image hydrogels upon injection to identify their location, volume, and pattern of delivery, features that are important to understand toward clinical translation. Using a hyaluronic acid (HA) hydrogel as an example, the aim of this study is to introduce radiopacity to hydrogels by encapsulating a clinically used contrast agent (Omnipaque Iohexol, GE Healthcare) for imaging upon placement in the myocardium. Specifically, iohexol is encapsulated into shear‐thinning and self‐healing hydrogels formed through the mixing of HA‐hydrazide and HA‐aldehyde. Upon examination of a range of iohexol concentrations, a concentration of 100 mg mL−1 iohexol is deemed optimal based on the greatest contrast, while maintaining hydrogel mechanical properties and acceptable injection forces. In an acute porcine model of MI, hybrid single‐photon emission computed tomography/computed tomography (SPECT/CT) perfusion imaging is performed immediately and 3–4 days after hydrogel delivery to assess radiopacity and verify the hydrogel location within the perfusion defect. Hybrid SPECT/CT imaging demonstrates excellent radiopacity of the hydrogel within the perfusion defect immediately after intramyocardial hydrogel injection, demonstrating the feasibility of this method for short‐term noninvasive hydrogel monitoring.

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
Rebuilding Postinfarcted Cardiac Functions by Injecting TIIA@PDA Nanoparticle-Cross-linked ROS-Sensitive Hydrogels

Wei Wang,Jingrui Chen,Min Li,Huizhen Jia,Xiaoxu Han,Jingxuan Zhang,Yang Zou,Baoyu Tan,Wei Liang,Yingying Shang,Qian Xu,A. Sigen,Wenxin Wang,Jingyuan Mao,Xiumei Gao,Guanwei Fan,Wenguang Liu

DOI: https://doi.org/10.1021/acsami.8b20158

IF: 9.5

2018-01-01

ACS Applied Materials & Interfaces

Abstract:Drug-loaded injectable hydrogels have been proven to possess huge potential for applications in tissue engineering. However, increasing the drug loading capacity and regulating the release system to adapt to the microenvironment after myocardial infarction face a huge challenge. In this research, an ROS-sensitive injectable hydrogel strengthened by self-nanodrugs was constructed. A hyperbranched ROS-sensitive macromer (HB-PBAE) with multiacrylate end groups was synthesized through dynamic controlled Michael addition. Meanwhile, a simple protocol based on dopamine polymerization was employed to generate a polydopamine (PDA) layer deposited on the tanshinone IIA (TIIA) nanoparticles (NPs) formed from spontaneous hydrophobic self-assembly. The HB-PBAE reacted with thiolate-modified hyaluronic acid (HA-SH) to form an in situ hydrogel, where TIIA@PDA NPs can be conveniently entrapped through the chemical cross-link between thiolate and quinone groups on PDA, which doubles the modulus of hydrogels. The in vivo degradation behavior of the hydrogels was characterized by MRI, exhibiting a much slower degradation behavior that is markedly different from that of in vitro. Importantly, a significant improvement of cardiac functions was achieved after hydrogel injection in terms of increased ejection fraction and decreased infarction size, accompanied by inhibition of the expression of inflammation factors, such as IL-1β, IL-6, and TNF-α.
Delivery of Alginate-Chitosan Hydrogel Promotes Endogenous Repair and Preserves Cardiac Function in Rats with Myocardial Infarction

Biyong Deng,Li Shen,Yizhe Wu,Yunli Shen,Xuefeng Ding,Shuyang Lu,Jianguo Jia,Juying Qian,Junbo Ge

DOI: https://doi.org/10.1002/jbm.a.35232

2015-01-01

Journal of Biomedical Materials Research Part A

Abstract:The regenerative potential of alginate-chitosan composite in bone and cartilage tissue has been well documented, but its potential utility in cardiac tissue engineering has remained unknown. This study sought to determine whether early intramyocardial injection of alginate-chitosan could prevent left ventricular (LV) remodeling after myocardial infarction (MI), leading to a more favorable course of tissue restoration. In a rat model of acute MI, local injection of alginate-chitosan hydrogel into the peri-infarct zone preserved scar thickness, attenuated infarct expansion, and reduced scar fibrosis after 8 weeks, concomitantly with promoting increased angiogenesis and greater recruitment of endogenous repair at the infarct zone. Furthermore, this treatment prevented cell apoptosis, induced cardiomyocyte cell cycle re-entry. The cardiac function of the control-injected animals deteriorated over the 8-week course, while that of the hydrogel-injected animals did not.In addition, the hydrogel did not exacerbate inflammation in the heart. Intramyocardial injection of alginate-chitosan hydrogel represents a useful strategy to treat MI. It demonstrated marked therapeutic efficacies on various tissue levels after extensive MI, as well as potential to induce endogenous cardiomyocyte proliferation and recruit cardiac stem cells. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 907-918, 2015.
Comparative effectiveness of myocardial patches and intramyocardial injections in treating myocardial infarction with a MitoQ/hydrogel system

Ying Tan,Yali Nie,Lei ZhengWen,Zhi Zheng

DOI: https://doi.org/10.1039/d4tb00573b

2024-06-19

Abstract:In cardiac tissue engineering, myocardial surface patches and hydrogel intramyocardial injections represent the two primary hydrogel-based strategies for myocardial infarction (MI) treatment. However, the comparative effectiveness of these two treatments remains uncertain. Therefore, this study aimed to compare the effects of the two treatment modalities by designing a simple and reproducible hydrogel cross-linked with γ-PGA and 4-arm-PEG-SG. To improve mitochondrial damage in cardiomyocytes (CMs) during early MI, we incorporated the mitochondria-targeting antioxidant MitoQ into the hydrogel network. The hydrogel exhibited excellent biodegradability, biocompatibility, adhesion, and injectability in vitro. The hydrogel was utilized for rat MI treatment through both patch adhesion and intramyocardial injections. In vivo results demonstrated that the slow release of MitoQ peptide from the hydrogel hindered ROS production in CM, alleviated mitochondrial damage, and enhanced CM activity within 7 days, effectively inhibiting MI progression. Both hydrogel intramyocardial injections and patches exhibited positive therapeutic effects, with intramyocardial injections demonstrating superior efficacy in terms of cardiac function and structure in equivalent treatment cycles. In conclusion, we developed a MitoQ/hydrogel system that is easily prepared and can serve as both a myocardial patch and an intramyocardial injection for MI treatment, showing significant potential for clinical applications.
Waiting Time in an (S - 1, S) Inventory System

Isamu Higa,A. Feyerherm,A. Machado

DOI: https://doi.org/10.1287/opre.23.4.674

IF: 2.7

1975-08-01

Operational Research

Abstract:Steady-state distribution functions are derived for waiting time in an S-1, S inventory system in which arrivals are governed by members of the geometric Poisson family, resupply times are independently and identically distributed negative exponential variates, and service is on a first-come-first-served basis. For small values of S, probabilities can be computed readily from the final forms of the distribution functions using gamma and exponential function tables.
Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction

Todd D Johnson,Karen L Christman

DOI: https://doi.org/10.1517/17425247.2013.739156

2012-11-09

Expert Opinion on Drug Delivery

Abstract:INTRODUCTION: Heart failure following myocardial infarction (MI) impacts millions of people each year in the US. The field of tissue engineering has developed several potential therapies for treating MI including injectable acellular hydrogels. These injectable biomaterials can either be synthetic or naturally derived, and have the potential to be delivered minimally invasively.AREAS COVERED: This review covers the different methods of delivery and presents the initial work on the use of injectable biomaterial scaffolds alone to improve cardiac function post-MI. Several naturally derived materials including alginate, collagen, chitosan, decellularized tissues, fibrin, hyaluronic acid, keratin, and Matrigel, as well as a few synthetic materials have shown promise on their own without the addition of therapeutics such as cells or growth factors. These biomaterials can be potentially delivered via endocardial, epicardial, or intracoronary injections and some can even utilize current catheter technology, indicating a potential for avoiding invasive surgical procedures. Once injected into the wall of the heart, these hydrogels create a scaffold that provides biochemical and structural cues, and the ability for cellular infiltration and remodeling of the local environment.EXPERT OPINION: Injectable biomaterials have several crucial challenges that should be over come to design optimal therapies for MI and heart failure, including optimizing material properties, methods of injection and understanding the mechanisms of action. But, studies in both small and large animals have shown significant improvement in important parameters including wall thickness, vascularization of the ischemic region, left ventricular volumes, and cardiac function. Thus, the application of injectable biomaterials shows promise for developing into new therapies to treat MI, potentially improving millions of lives.

pharmacology & pharmacy
An injectable alginate/fibrin hydrogel encapsulated with cardiomyocytes and VEGF for myocardial infarction treatment

Chunxia Liu,Yong Wu,Hong Yang,Kunyan Lu,Haixin Zhang,Yuanyuan Wang,Jingjing Wang,Linan Ruan,Zhenya Shen,Qian Yu,Yanxia Zhang

DOI: https://doi.org/10.1016/j.jmst.2022.11.002

IF: 10.319

2022-11-24

Journal of Materials Science and Technology

Abstract:Myocardial infarction (MI) is one of the typical cardiovascular diseases, which persist as the leading cause of death globally. Due to the poor regenerative capability of endogenous cardiomyocytes (CMs), the transplantation of exogenous CMs becomes a promising option for MI treatment. However, the low retention and survival of transplanted cells still limit the clinical translation of cell therapy. Herein, an alginate/fibrin-based injectable hydrogel was prepared for the delivery of neonatal CMs and an angiogenesis agent vascular endothelial growth factor (VEGF) locally to the infarcted area of the heart. This hydrogel combined the specific advantages of alginate and fibrin with proper mechanical properties and cell affinity, showing good biocompatibility to support the retention and integration of the transplanted CMs to the host myocardium. Moreover, the delivered VEGF was favorable for the blood recovery to mitigate the ischemic microenvironment of the infarcted area and thus improved the survival of the transplanted CMs. Intramyocardial injection of this hydrogel to the infarcted area of the heart promoted angiogenesis, inhibited fibrosis, and improved cardiac function, exhibiting great potential for MI treatment.

materials science, multidisciplinary,metallurgy & metallurgical engineering
An MMP-degradable and conductive hydrogel to stabilize HIF-1 for recovering cardiac functions

Xiaojuan Wei,Si Chen,Tian Xie,Hongchi Chen,Xin Jin,Jumin Yang,Shafaq Sahar,Huanlei Huang,Shuoji Zhu,Nanbo Liu,Changjiang Yu,Ping Zhu,Wei Wang,Wei Zhang

DOI: https://doi.org/10.7150/thno.63481

IF: 11.6

2022-01-01

Theranostics

Abstract:Rationale: Although a few injectable hydrogels have shown a reliable biosafety and a moderate promise in treating myocardial infarction (MI), the updated hydrogel systems with an on-demand biodegradation and multi-biofunctions to deliver therapeutic drug would achieve more prominent efficacy in the future applications. In this report, a conductive and injectable hydrogel crosslinked by matrix metalloproteinasesensitive peptides (MMP-SP) was rationally constructed to stabilize hypoxia-inducible factor-1 alpha (HIF-1 alpha) to recover heart functions after MI. Methods: Firstly, tetraaniline (TA) was incorporated into partially oxidized alginate (ALG-CHO) to endow the hydrogels with conductivity. The 1,4-dihydrophenonthrolin-4-one-3-carboxylic acid (DPCA) nanodrug was manufactured with high drug loading capacity and decorated with polymerized dopamine (PDA) to achieve a stable release of the drug. Both ALG-CHO and DPCA@PDA can be cross-linked by thiolated hyaluronic acid (HA-SH) and thiolated MMP-SP to construct a MMP-degradable and conductive hydrogel. After administration in the infarcted heart of rats, echocardiographic assessments, histological evaluation, and RT-PCR were used to evaluate therapeutic effects of hydrogels. Results: The cell viability and the results of subcutaneous implantation verify a good cytocompatibility and biocompatibility of the resulting hydrogels. The hydrogel shows remarkable strength in decreasing the expression of inflammatory factors, maintaining a high level of HIF-1 alpha to promote the vascularization, and promoting the expression of junctional protein connexin 43. Meanwhile, the multifunctional hydrogels greatly reduce the infarcted area (by 33.8%) and improve cardiac functions dramatically with ejection fraction (EF) and fractional shortening (FS) being increased by 31.3% and 19.0%, respectively. Conclusion: The as-prepared hydrogels in this report achieve a favorable therapeutic effect, offering a promising therapeutic strategy for treating heart injury.
Injectable Peptide Hydrogels Loaded with Murine Embryonic Stem Cells Relieve Ischemia In Vivo after Myocardial Infarction

Abhishek Roy,Lei Hao,Jamie Francisco,Jin Guan,Satvik Mareedu,Peiyong Zhai,Joseph Dodd-o,Corey Heffernan,Dominic Del Re,Eun Jung A. Lee,Vivek A. Kumar

DOI: https://doi.org/10.1021/acs.biomac.3c01345

2024-01-31

Biomacromolecules

Abstract:Myocardial infarction (MI) is a major cause of morbidity and mortality worldwide, especially in aging and metabolically unhealthy populations. A major target of regenerative tissue engineering is the restoration of viable cardiomyocytes to preserve cardiac function and circumvent the progression to heart failure post-MI. Amelioration of ischemia is a crucial component of such restorative strategies. Angiogenic β-sheet peptides can self-assemble into thixotropic nanofibrous hydrogels. These syringe aspiratable cytocompatible gels were loaded with stem cells and showed excellent cytocompatibility and minimal impact on the storage and loss moduli of hydrogels. Gels with and without cells were delivered into the myocardium of a mouse MI model (LAD ligation). Cardiac function and tissue remodeling were evaluated up to 4 weeks in vivo. Injectable peptide hydrogels synergized with loaded murine embryonic stem cells to demonstrate enhanced survival after intracardiac delivery during the acute phase post-MI, especially at 7 days. This approach shows promise for post-MI treatment and potentially functional cardiac tissue regeneration and warrants large-scale animal testing prior to clinical translation.

polymer science,biochemistry & molecular biology,chemistry, organic
Detection of human monocyte-reactive alloantibodies by flow cytometry after selective downmodulation of the Fc receptor I.

RW Kuijpers,M. Dooren,A. Von Dem Borne,W H Ouwehand

DOI: https://doi.org/10.1182/BLOOD.V78.8.2150.BLOODJOURNAL7882150

IF: 20.3

1991-10-15

Blood

Abstract:Monocyte-reactive human alloantibodies may be of importance in situations such as transfusion reactions and bone marrow and kidney transplantation. So far, only complement-binding monocyte-reactive antibodies can be detected with a cytotoxicity assay. No antiglobulin assays are yet available that also detect noncomplement-fixing monocyte-reactive antibodies. The binding of monomeric IgG with high affinity to the Fc receptor I (FcRI) on monocytes has severely hampered the development of such an assay until now. We report on the selective removal of the FcRI from monocytes to test human sera in a flow cytofluorometry assay for the presence of monocyte-reactive IgG alloantibodies. Selective downmodulation of FcRI was accomplished by incubating the cells with murine monoclonal antibodies against FcRI followed by a second incubation with goat-antimouse IgG polyclonal antibodies. With such modified cells, human complement-binding and noncomplement-binding IgG and IgM alloantibodies against polymorphic determinants of the HLA class I and II glycoproteins, the human monocyte antigen system and polymorphic antigenic determinants of the LFA complex, can be detected in a sensitive and reproducible manner.
An injectable conductive hydrogel with dual responsive release of rosmarinic acid improves cardiac function and promotes repair after myocardial infarction

Linghong Zhang,Zhongwu Bei,Tao Li,Zhiyong Qian

DOI: https://doi.org/10.1016/j.bioactmat.2023.07.007

IF: 18.9

2023-07-14

Bioactive Materials

Abstract:Highlights • An injectable self-healing conductive hydrogel with pH/ROS dual-responsive drug release was prepared for the treatment of MI. • The OGDPR hydrogel has conductivity (6.27 × 10 −4 S/cm) and elastic modulus (45.35 kPa) matching those of the natural heart. • The biocompatible hydrogel can resist oxidation, promote macrophage polarization and tube formation of endothelial cells. • The hydrogel can protect cardiac function, reduce arrhythmia susceptibility, and reduce infarct size and fibrosis after MI. • The hydrogel can reduce apoptosis and inflammation, and promote angiogenesis and the expression of cardiac-specific markers. Myocardial infarction (MI) causes irreversible damage to the heart muscle, seriously threatening the lives of patients. Injectable hydrogels have attracted extensive attention in the treatment of MI. By promoting the coupling of mechanical and electrical signals between cardiomyocytes, combined with synergistic therapeutic strategies targeting the pathological processes of inflammation, proliferation, and fibrotic remodeling after MI, it is expected to improve the therapeutic effect. In this study, a pH/ROS dual-responsive injectable hydrogel was developed by modifying xanthan gum and gelatin with reversible imine bond and boronic ester bond double crosslinking. By encapsulating polydopamine-rosmarinic acid nanoparticles to achieve on-demand drug release in response to the microenvironment of MI, thereby exerting anti-inflammatory, anti-apoptotic, and anti-fibrosis effects. By adding conductive composites to improve the conductivity and mechanical strength of the hydrogel, restore electrical signal transmission in the infarct area, promote synchronous contraction of cardiomyocytes, avoid induced arrhythmias, and induce angiogenesis. Furthermore, the multifunctional hydrogel promoted the expression of cardiac-specific markers to restore cardiac function after MI. The in vivo and in vitro results demonstrate the effectiveness of this synergistic comprehensive treatment strategy in MI treatment, showing great application potential to promote the repair of infarcted hearts. Graphical abstract Download : Download high-res image (275KB) Download : Download full-size image

engineering, biomedical,materials science, biomaterials

Endogenous cholecystokinin’s satiating action increases during estrus in female rats

Intramyocardial Injection of a Fully Synthetic Hydrogel Attenuates Left Ventricular Remodeling Post Myocardial Infarction.

Timing Effect of Intramyocardial Hydrogel Injection for Positively Impacting Left Ventricular Remodeling after Myocardial Infarction.

Abstract 16617: Multimodality Imaging Approach in Delivery and Tracking of a Novel Imageable Hydrogel in a Chronic Porcine Infarct Model

BIODEGRADABLE, THERMALLY RESPONSIVE HYDROGELS FOR MYOCARDIAL INFARCTION TREATMENT

Myocardial Injection of a Thermoresponsive Hydrogel with Reactive Oxygen Species Scavenger Properties Improves Border Zone Contractility

Matrix Metalloproteinase-Targeted SPECT/CT Imaging for Evaluation of Therapeutic Hydrogels for the Early Modulation of Post-Infarct Myocardial Remodeling

Design of a Coupled Thermoresponsive Hydrogel and Robotic System for Postinfarct Biomaterial Injection Therapy.

Intervening to preserve function in ischemic cardiomyopathy with a porous hydrogel and extracellular matrix composite in a rat myocardial infarction model

Tuning Biphenyl Dioxygenase for Extended Substrate Specificity and Enhanced Activity

Imaging of Injectable Hydrogels Delivered into Myocardium with SPECT/CT

Rebuilding Postinfarcted Cardiac Functions by Injecting TIIA@PDA Nanoparticle-Cross-linked ROS-Sensitive Hydrogels

Delivery of Alginate-Chitosan Hydrogel Promotes Endogenous Repair and Preserves Cardiac Function in Rats with Myocardial Infarction

Comparative effectiveness of myocardial patches and intramyocardial injections in treating myocardial infarction with a MitoQ/hydrogel system

Waiting Time in an (S - 1, S) Inventory System

Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction

An injectable alginate/fibrin hydrogel encapsulated with cardiomyocytes and VEGF for myocardial infarction treatment

An MMP-degradable and conductive hydrogel to stabilize HIF-1 for recovering cardiac functions

Injectable Peptide Hydrogels Loaded with Murine Embryonic Stem Cells Relieve Ischemia In Vivo after Myocardial Infarction

Detection of human monocyte-reactive alloantibodies by flow cytometry after selective downmodulation of the Fc receptor I.

An injectable conductive hydrogel with dual responsive release of rosmarinic acid improves cardiac function and promotes repair after myocardial infarction